Published on January 30, 2010 at 2:54 AM
Reportlinker.com announces that a new market research report is available in its catalogue: DNA Probes-Based Diagnostics - A Worldwide Market Review
http://www.reportlinker.com/p0164348/DNA-Probes-Based-Diagnostics---A-Worldwide-Market-Review.html
DNA probes-based diagnostics is an emerging application area in the in-vitro diagnostics industry. DNA probes, popular across the medical diagnostics industry, determine the presence of a suspected disease caused by an organism or pathogen. Based on the amount of target DNA present, probes can be used either directly to detect target DNA, or indirectly target DNA through amplification that creates a number of copies of specific nucleotide. Increased automation of diagnostic tests, discovery of new diagnostic markets, rising investments in pharmaceutical and pharmacogenomics research, and advancements in DNA array technologies are major growth facilitators for the DNA probes-based diagnostic products market.
In the area of molecular in-vitro diagnostics, DNA based diagnostics represent the most attractive, and fast growing clinical diagnostics technology primarily due to high levels of reliability, sensitivity, and rapidity. Numerous technology breakthroughs in the area of DNA diagnostics include PCR-based techniques, DNA microarrays and microfluidics, fluorescent in situ hybridization (FISH), SNP detection, and DNA nanotechnology, among several others. Breaking from the realm of research, current applications of DNA diagnostics are becoming widespread, with millions of samples from blood, hair and tissues, being analyzed for the positive identification of pathogens and diseases.
These and other market data and trends are presented in "DNA Probes-based Diagnostics: A Worldwide Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
SOURCE Reportlinker
5a8138a9-9738-401d-8aaa-4dc109094701|0|.0
Posted in: Device / Technology News
Tags: Cancer, Diagnostics, DNA, Evolution, Genetics, Genomics, Hepatitis C, Microfluidics, Nanotechnology, Pathogen, Pharmacogenomics, Virus